Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 7,110.00
-280.00 (-3.79%)
At close: May 28, 2026
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 85.46 billion as of May 28, 2026. Its market cap has decreased by -51.96% in one year.
Market Cap
85.46B
Enterprise Value
174.49B
Revenue
19.02B
Ranking
n/a
PE Ratio
31.26
Stock Price
7,110.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 85.46B, a decrease of -76.30%. That is a compound annual growth rate of -25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 85.46B | -44.67% |
| Dec 30, 2025 | 154.45B | -14.96% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 144.62B |
| Vaxcell-Bio Therapeutics | 138.15B |
| MedPacto | 129.22B |
| ENCell | 123.77B |
| Amicogen | 120.48B |
| GeneOne Life Science | 106.72B |
| iNtRON Biotechnology | 95.47B |
| CG Invites | 88.51B |